(1997). Birembaut P: Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses.
(2001). Birembaut P: Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness.
Birembaut P: Vimentin contributes to human mammary epithelial cell migration.
(2005). Cancer therapy through control of cell migration. Curr Cancer Drug Targets
(2007). CJ: Green tea catechin inhibits ephrinA1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
(1998). CY: Induction of apoptosis in prostate cancer cell lines by the green tea component,
(2004). Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene
(1997). EW: Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest
(1994). Foidart JM: Epithelial-tomesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A.
(1999). GI: Matrix metalloproteinases in tumour invasion and metastasis.
(2005). GS: Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
(2007). H: Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene
(2003). Iguchi A: Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis
(2005). Iguchi A: Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Arterioscler Thromb Vasc Biol
(1998). Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts.
(2003). Induction of apoptosis by EGCG in selected tumour cell lines in vitro. Folia Histochem Cytobiol
(1981). Influence of collagen gel on the orientation of epithelial cell polarity: follicle formation from isolated thyroid cells and from preformed monolayers.
(2003). IP: Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions.
(2004). Iwasaka T: The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol Oncol
(2005). JM: 3D culture model and computer-assisted videomicroscopy to analyze migratory behavior of noninvasive and invasive bronchial epithelial cells.
(2004). Katiyar SK: EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
(1989). KleinSzanto AJ: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res
(1996). Komiya T: Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res
(2001). Liang YC: Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
(2003). M: Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
(2003). Matsui-Yuasa I: Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci
(2004). NE: VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood
(2002). Pezzato E, Garbisa S: (-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface. Lab Invest
(1998). Proteases--invasion and more. Nature
(1997). Puchelle E: Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil Cytoskeleton
(2002). R: Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim Biophys Acta
(2005). Repressions of MMP-9 expression and NFkappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate. Biomed Pharmacother
(2008). RK: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci
(2005). Shimosegawa T: Green tea polyphenol epigallocatechin-3-gallate blocks PDGFinduced proliferation and migration of rat pancreatic stellate cells.
(1997). Skrzypczak-Jankun E: Why drinking green tea could prevent cancer. Nature
(1991). Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res
(2002). T: Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas. Lung Cancer
(2005). The intermediate filament protein vimentin is a new target for epigallocatechin gallate.
(2003). Tong WY: Inhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acid.
(2005). VB: Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc Res
(2002). Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer
(2000). Yang CS: Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis